郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

肿瘤模型FGFR1 clustering with engineered tetravalent antibody improves the efficiency and modifies the mechanism of receptor internalization.

期刊：Molecular oncology发表年份：2020作者：Marta Pozniak; Aleksandra Sokolowska-Wedzina; Kamil Jastrzebski; Jakub Szymczyk; Natalia Porebska; Mateusz Adam Krzyscik; Malgorzata Zakrzewska; Marta Miaczynska; Jacek Otlewski; Lukasz Opalinski
阅读更多 →

肿瘤模型Discovery of first-in-class multi-target adenosine A2A receptor antagonists-carbonic anhydrase IX and XII inhibitors. 8-Amino-6-aryl-2-phenyl-1,2,4-triazolo [4,3-a]pyrazin-3-one derivatives as new potential antitumor agents.

期刊：European journal of medicinal chemistry发表年份：2020作者：Costanza Ceni; Daniela Catarzi; Flavia Varano; Diego Dal Ben; Gabriella Marucci; Michela Buccioni; Rosaria Volpini; Andrea Angeli; Alessio Nocentini; Paola Gratteri; Claudiu T Supuran; Vittoria Colotta
阅读更多 →

肿瘤模型Structure-Based Virtual Screening, Synthesis and Biological Evaluation of Potential FAK-FAT Domain Inhibitors for Treatment of Metastatic Cancer.

期刊：Molecules (Basel, Switzerland)发表年份：2020作者：Sahar B Kandil; Samuel R Jones; Sonia Smith; Stephen E Hiscox; Andrew D Westwell
阅读更多 →

肿瘤模型Bispecific Targeting of PD-1 and PD-L1 Enhances T-cell Activation and Antitumor Immunity.

期刊：Cancer immunology research发表年份：2020作者：Helen Kotanides; Yiwen Li; Maria Malabunga; Carmine Carpenito; Scott W Eastman; Yang Shen; George Wang; Ivan Inigo; David Surguladze; Anthony L Pennello; Krishnadatt Persaud; Sagit Hindi; Michael Topper; Xinlei Chen; Yiwei Zhang; Danielle K Bulaon; T
阅读更多 →